CSNK1G2P1

Across TCGA pan-cancer cohorts, CSNK1G2P1 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of CSNK1G2P1’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where CSNK1G2P1 RNA is repressed in tumor relative to normal tissue. In most cancer types CSNK1G2P1 is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

THCA, CHOL, and STAD are the cancer types where CSNK1G2P1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CSNK1G2P1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	All	II,III,IV	−0.075	<.001	8	view →
CHOL	All	All	+0.087	<.001	4	view →
STAD	All	II,III,IV	+0.199	.011	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

CSNK1G2P1–THCA

Open the THCA breakdown →